Peritoneal Dialysis Market by Treatment Type, Product Type, and End User - Global Opportunity Analysis and Industry Forecast, 2018-2025

  • ID: 4580647
  • Report
  • Region: Global
  • 205 pages
  • Allied Analytics LLP
1 of 4
Peritoneal dialysis (PD) is a form of dialysis that uses the inner lining of abdomen to filter blood when the kidneys are not functioning effectively. This procedure drains waste and excess fluid from body by using peritoneal membrane; it can be performed manually or via automated systems.

The global peritoneal dialysis market generated $3,213 million in 2017, and is projected to reach $5,074 million by 2025, growing at a CAGR of 5.8% from 2018 to 2025. The peritoneal dialysis market is expected to grow at a significant rate during the forecast period, owing to increase in prevalence of end stage renal disease (ESRD), technological advancement in PD devices, and growth in awareness regarding automated peritoneal dialysis (APD). In addition, shortage of kidneys for transplantation and rise in prevalence of diabetes & hypertension further facilitate the growth of the market. However, stringent government regulations for the approval of PD devices and complications associated with peritoneal dialysis impede the market growth.

The global peritoneal dialysis market is segmented based on treatment type, product type, end user, and region. Based on treatment type, the market is classified as continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). Based on product type, the market is segmented as peritoneal dialysis solution, device, peritoneal dialysis set, catheter, and others. According to end user, the market is divided into home-based dialysis, and dialysis center & hospital based dialysis. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Treatment Type

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)

By Product Type

Peritoneal Dialysis Solution
Device
Peritoneal Dialysis Set
Catheter
Others

By End User

Home-Based Dialysis
Dialysis Center & Hospital Based Dialysis

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Baxter International Inc.
Cook Inc.
Fresenius Medical Care AG & Co. KGaA
Medionics International, Inc.
Medtronic Plc.
Newsol Technologies Inc.
Poly Medicure Limited
Renax Biomedical Tech. Co., Ltd.
Terumo Corp.
Utah Medical Products, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top investment pockets
3.3. Market share analysis, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the number of ESRD patients
3.4.1.2. Rise in incidence of diabetes & hypertension
3.4.1.3. Benefits of peritoneal dialysis over hemodialysis
3.4.1.4. Shortage of kidneys for transplantation
3.4.2. Restraints
3.4.2.1. Complications associated with peritoneal dialysis
3.4.2.2. Poor demand in underdeveloped countries
3.4.3. Opportunities
3.4.3.1. Rise in demand for home peritoneal dialysis treatment
3.4.3.2. Growth opportunities in the emerging markets
3.4.4. Impact analysis

CHAPTER 4: PERITONEAL DIALYSIS MARKET, BY TREATMENT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Continuous ambulatory peritoneal dialysis (CAPD)
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Automated peritoneal dialysis (APD)
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: PERITONEAL DIALYSIS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Peritoneal dialysis solutions
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Peritoneal dialysis devices
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Peritoneal dialysis sets
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Peritoneal dialysis catheters
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Other peritoneal dialysis products
5.6.1. Market size and forecast
5.6.2. Market analysis, by country

CHAPTER 6: PERITONEAL DIALYSIS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Home-based dialysis
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Dialysis centers & hospital-based dialysis
6.3.1. Market size and forecast
6.3.2. Market analysis, by country

CHAPTER 7: PERITONEAL DIALYSIS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. peritoneal dialysis market, by treatment type
7.2.2.1.2. U.S. peritoneal dialysis market, by product
7.2.2.1.3. U.S.peritoneal dialysis market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada peritoneal dialysis market, by treatment type
7.2.2.2.2. Canada peritoneal dialysis market, by product
7.2.2.2.3. Canada peritoneal dialysis market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico peritoneal dialysis market, by treatment type
7.2.2.3.2. Mexico peritoneal dialysis market, by product
7.2.2.3.3. Mexico peritoneal dialysis market, by end user
7.2.3. North America peritoneal dialysis market, by treatment type
7.2.4. North America peritoneal dialysis market, by product
7.2.5. North America peritoneal dialysis market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany peritoneal dialysis market, by treatment type
7.3.2.1.2. Germany peritoneal dialysis market, by product
7.3.2.1.3. Germany peritoneal dialysis market, by end user
7.3.2.2. France
7.3.2.2.1. France peritoneal dialysis market, by treatment type
7.3.2.2.2. France peritoneal dialysis market, by product
7.3.2.2.3. France peritoneal dialysis market, by end user
7.3.2.3. UK
7.3.2.3.1. UK peritoneal dialysis market, by treatment type
7.3.2.3.2. UK peritoneal dialysis market, by product
7.3.2.3.3. UK peritoneal dialysis market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy peritoneal dialysis market, by treatment type
7.3.2.4.2. Italy peritoneal dialysis market, by product
7.3.2.4.3. Italy peritoneal dialysis market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain peritoneal dialysis market, by treatment type
7.3.2.5.2. Spain peritoneal dialysis market, by product
7.3.2.5.3. Spain peritoneal dialysis market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe peritoneal dialysis market, by treatment type
7.3.2.6.2. Rest of Europe peritoneal dialysis market, by product
7.3.2.6.3. Rest of Europe peritoneal dialysis market, by end user
7.3.3. Europe peritoneal dialysis market, by treatment type
7.3.4. Europe peritoneal dialysis market, by product
7.3.5. Europe peritoneal dialysis market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan peritoneal dialysis market, by treatment type
7.4.2.1.2. Japan peritoneal dialysis market, by product
7.4.2.1.3. Japan peritoneal dialysis market, by end user
7.4.2.2. China
7.4.2.2.1. China peritoneal dialysis market, by treatment type
7.4.2.2.2. China peritoneal dialysis market, by product
7.4.2.2.3. China peritoneal dialysis market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia peritoneal dialysis market, by treatment type
7.4.2.3.2. Australia peritoneal dialysis market, by product
7.4.2.3.3. Australia peritoneal dialysis market, by end user
7.4.2.4. India
7.4.2.4.1. India peritoneal dialysis market, by treatment type
7.4.2.4.2. India peritoneal dialysis market, by product
7.4.2.4.3. India peritoneal dialysis market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea peritoneal dialysis market, by treatment type
7.4.2.5.2. South Korea peritoneal dialysis market, by product
7.4.2.5.3. South Korea peritoneal dialysis market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific peritoneal dialysis market, by treatment type
7.4.2.6.2. Rest of Asia-Pacific peritoneal dialysis market, by product
7.4.2.6.3. Rest of Asia-Pacific peritoneal dialysis market, by end user
7.4.3. Asia-Pacific peritoneal dialysis market, by treatment type
7.4.4. Asia-Pacific peritoneal dialysis market, by product
7.4.5. Asia-Pacific peritoneal dialysis market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil peritoneal dialysis market, by treatment type
7.5.2.1.2. Brazil peritoneal dialysis market, by product
7.5.2.1.3. Brazil peritoneal dialysis market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia peritoneal dialysis market, by treatment type
7.5.2.2.2. Saudi Arabia peritoneal dialysis market, by product
7.5.2.2.3. Saudi Arabia peritoneal dialysis market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa peritoneal dialysis market, by treatment type
7.5.2.3.2. South Africa peritoneal dialysis market, by product
7.5.2.3.3. South Africa peritoneal dialysis market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA peritoneal dialysis market, by treatment type
7.5.2.4.2. Rest of LAMEA peritoneal dialysis market, by product
7.5.2.4.3. Rest of LAMEA peritoneal dialysis market, by end user
7.5.3. LAMEA peritoneal dialysis market, by treatment type
7.5.4. LAMEA peritoneal dialysis market, by product
7.5.5. LAMEA peritoneal dialysis market, by end user

CHAPTER 8: COMPANY PROFILES
8.1. Baxter International Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Cook Medical Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. Fresenius Medical Care AG & Co. KGaA
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Medtronic Plc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Medionics International, Inc.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. Newsol Technologies Inc.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.7. Poly Medicure Ltd.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. Renax Biomedical Tech. Co., Ltd.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. Terumo Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Utah Medical Products, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Peritoneal Dialysis Market, by Treatment, Product, and End User: Global Opportunity Analysis and Industry Forecast, 20182025" the global market was valued at $3,213 million in 2017, and is expected to reach $5,074 million by 2025, growing at a CAGR of 5.8% from 2018 to 2025.

Peritoneal dialysis (PD) is a treatment that uses the inner lining of abdomen, called the peritoneum and a dialysis solution to purify blood when the kidneys are not functioning adequately. PD is performed manually or via automated systems. Increase in prevalence of ESRD, growth in demand for home dialysis treatment and technological advancement in cyclers & PD devices are driving the market growth. In addition, peritoneal dialysis offers some advantages, such as needle free treatment, portability, treatment convenience, and less dietary restrictions that further fuel the market growth globally. However, risk associated with peritoneal dialysis such as peritonitis, infection, weight gain, and hernia is expected to negatively impact the growth of the peritoneal dialysis market.

Peritoneal dialysis is performed by using machines or via manual method. Based on treatment type, market is segmented as continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). At present, CAPD is a major revenue generating segment due to lower cost, portability, and freedom from machines. On the other side, APD is projected to show fastest market growth during the forecast period owing to its advantages such as flexibility with daytime routine, safety, and convenience.

Based on product, the market is categorized as peritoneal dialysis solution, device, peritoneal dialysis set, catheter, others. Presently, peritoneal dialysis solution segment is a major revenue contributor and is anticipated to maintain its dominance during the forecast period. Peritoneal dialysis solution plays a vital role in every PD procedure as these solutions facilitate exchange of fluid to remove waste products from body. However, devices segment is anticipated to show fastest market growth, due to the technological advancement in devices and increase in demand for automated peritoneal dialysis (APD).

Based on end user, home based dialysis occupied the largest share in 2017, and is anticipated to continue its dominance during the forecast period, due to availability of dialysis machines with greater convenience and better clinical outcomes for homecare use. Furthermore, increase in demand for home healthcare among dialysis patients further drives the growth of home based dialysis segment.

Key findings of the Peritoneal Dialysis Market:

Based on treatment, the automated peritoneal dialysis (APD) segment is expected to show the fastest market growth, and is expected to grow at a CAGR of 6.7% from 2018 to 2025.
Based on product, peritoneal dialysis solution segment held more than one-third share in 2017 and is expected to remain dominant throughout the forecast period.
Based on end user, the home-based dialysis held more than two-third of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.9% during the forecast period.

North America was the highest revenue contributor to the global peritoneal dialysis market in 2017, and is expected to remain dominant during the forecast period. Factors such as high awareness about advanced APD technique, developed healthcare infrastructure, and rise in prevalence ESRD in the region. On the other hand, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to growth in health awareness, rise in number of ESRD patients along with the increase in prevalence of diabetes & hypertension, and surge in demand for home dialysis treatment.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll